Cholinesterase inhibitors for mild cognitive impairment
23 results
1 - 23
Cholinesterase inhibitors for mild cognitive impairment
Cholinesterase inhibitors for mild cognitive impairment - Treatment of a patient with memory disease
- Donepezil for mild cognitive impairment: Cochrane systematic review
Italian guideline on diagnosing and managing dementia and mild cognitive impairment in adults- Low-quality evidence: Adding traditional Chinese herbs to donepezil improves cognitive function in adults with mild impairment
- Cholinesterase inhibitors cause fewer falls but more syncope in adults with neurocognitive disorders
- Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia
- Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta‐analysis
- Memantine for Alzheimer’s disease
- Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment
- Folic acid with or without vitamin B12 for cognition and dementia
- Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people
- Interventions for preventing falls in Parkinson's disease
- Donepezil for vascular cognitive impairment: Cochrane systematic review
- Donepezil for dementia due to Alzheimer's disease
- Continuation and maintenance treatments for depression in older people
- Memantine for dementia